18.50
price down icon0.27%   -0.05
after-market Dopo l'orario di chiusura: 18.75 0.25 +1.35%
loading
Precedente Chiudi:
$18.55
Aprire:
$18.25
Volume 24 ore:
1.01M
Relative Volume:
1.19
Capitalizzazione di mercato:
$1.74B
Reddito:
$577.74M
Utile/perdita netta:
$-149.78M
Rapporto P/E:
-13.21
EPS:
-1.4
Flusso di cassa netto:
$-78.21M
1 W Prestazione:
+18.74%
1M Prestazione:
-1.44%
6M Prestazione:
+10.51%
1 anno Prestazione:
+51.27%
Intervallo 1D:
Value
$17.96
$18.97
Intervallo di 1 settimana:
Value
$15.25
$19.25
Portata 52W:
Value
$12.01
$34.13

Novocure Ltd Stock (NVCR) Company Profile

Name
Nome
Novocure Ltd
Name
Telefono
44 (0)15 3475 6700
Name
Indirizzo
NO. 4 THE FORUM, ST. HELIER
Name
Dipendente
1,453
Name
Cinguettio
@novocure
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
NVCR's Discussions on Twitter

Confronta NVCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NVCR
Novocure Ltd
18.50 1.74B 577.74M -149.78M -78.21M -1.40
Medical Devices icon
ABT
Abbott Laboratories
128.85 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
101.90 138.41B 17.55B 2.03B 2.37B 1.37
Medical Devices icon
SYK
Stryker Corp
365.06 129.62B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.16 107.92B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
76.04 40.53B 5.54B 4.18B 259.90M 7.00

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-02 Aggiornamento Evercore ISI In-line → Outperform
2024-10-16 Aggiornamento H.C. Wainwright Neutral → Buy
2023-11-20 Ripresa JP Morgan Neutral
2023-08-28 Downgrade H.C. Wainwright Buy → Neutral
2023-08-08 Aggiornamento Piper Sandler Neutral → Overweight
2023-08-04 Iniziato SVB Securities Outperform
2023-07-31 Aggiornamento Evercore ISI Underperform → In-line
2023-06-07 Aggiornamento Wedbush Underperform → Neutral
2023-05-16 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-03-17 Downgrade JP Morgan Neutral → Underweight
2023-01-06 Downgrade Wells Fargo Overweight → Equal Weight
2023-01-05 Reiterato H.C. Wainwright Buy
2022-11-29 Aggiornamento Wells Fargo Equal Weight → Overweight
2022-10-24 Downgrade Piper Sandler Overweight → Neutral
2022-07-05 Downgrade Evercore ISI In-line → Underperform
2022-05-16 Iniziato H.C. Wainwright Buy
2022-02-08 Iniziato Loop Capital Buy
2022-02-02 Aggiornamento Oppenheimer Perform → Outperform
2022-01-20 Aggiornamento Truist Hold → Buy
2022-01-03 Aggiornamento Evercore ISI Underperform → In-line
2021-07-01 Downgrade Mizuho Buy → Neutral
2021-04-14 Downgrade Wedbush Neutral → Underperform
2021-01-25 Reiterato Piper Sandler Overweight
2020-09-23 Iniziato Northland Capital Outperform
2020-09-18 Downgrade Wells Fargo Overweight → Equal Weight
2020-09-17 Downgrade Truist Buy → Hold
2020-06-01 Ripresa Oppenheimer Perform
2020-05-01 Downgrade Oppenheimer Outperform → Perform
2020-04-09 Downgrade Evercore ISI In-line → Underperform
2020-03-05 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-01-02 Downgrade Evercore ISI Outperform → In-line
2019-07-29 Aggiornamento SunTrust Hold → Buy
2019-07-26 Downgrade JP Morgan Overweight → Neutral
2019-07-26 Downgrade Wedbush Outperform → Neutral
2019-03-20 Iniziato SunTrust Hold
2018-11-02 Downgrade Wells Fargo Outperform → Market Perform
2018-07-16 Iniziato Evercore ISI Outperform
2018-04-18 Reiterato Mizuho Buy
2018-02-23 Reiterato Mizuho Buy
2017-05-24 Aggiornamento Wells Fargo Market Perform → Outperform
2016-07-29 Reiterato Wedbush Outperform
2016-01-19 Iniziato Barclays Underweight
2015-12-02 Iniziato Deutsche Bank Hold
Mostra tutto

Novocure Ltd Borsa (NVCR) Ultime notizie

pulisher
Apr 25, 2025

NovoCure Ltd [NVCR] Shares Jump Approximately 56.80% Over the Year - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on NovoCure, $38 price target - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

NovoCure Limited (NASDAQ:NVCR) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 25, 2025
pulisher
Apr 25, 2025

NovoCure (NASDAQ:NVCR) Cut to “Sell” at StockNews.com - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

NovoCure: Q1 Earnings Snapshot - Huron Daily Tribune

Apr 25, 2025
pulisher
Apr 25, 2025

Bank of Montreal Can Buys New Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Novocure’s Q1 2025: Revenue Growth and Strategic Advances - TipRanks

Apr 25, 2025
pulisher
Apr 24, 2025

NovoCure Ltd. Earnings Call: Growth Amid Financial Challenges - TipRanks

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure (NVCR) Stock Rises on Strong Quarterly Earnings - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure (NVCR) Sees Early Revenue from Lung Cancer Treatments | NVCR Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure’s device for metastatic NSCLC treatment gains CE Mark - MSN

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure (NVCR) Reports Strong Q1 Revenue Growth Amid Optune Lua Expansion - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Stocks of NovoCure Ltd (NVCR) are poised to climb above their peers - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Surpasses Q1 Expectations - Mitrade

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure (NVCR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Surpasses Q1 Expectations - The Motley Fool

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats E - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure Ltd earnings beat by $0.18, revenue topped estimates - Investing.com India

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure (NVCR) Surpasses Q1 Revenue Projections, Reports $154.99M | NVCR Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Ltd Reports Q1 2025 Earnings: EPS Loss of $0.31 Beats Estimate, Revenue of $155 Million Exceeds Expectations - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure Reports First Quarter 2025 Financial Results | NVCR Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Novocure Reports First Quarter 2025 Financial Results - TradingView

Apr 24, 2025
pulisher
Apr 24, 2025

NovoCure Ltd SEC 10-Q Report - TradingView

Apr 24, 2025
pulisher
Apr 23, 2025

Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025 - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

NovoCure's Earnings: A Preview - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Novocure (NVCR) to Showcase Key PANOVA-3 Trial Findings at ASCO 2025 | NVCR Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Novocure to Present Results from the Phase 3 PANOVA-3 Clinical T - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Novocure price target lowered to $34 from $42 at Piper Sandler - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Novocure (NVCR) Faces Revised Price Target Amid Investor Opportunities | NVCR Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Novocure sees 6% spike from EU nod for electric lung cancer therapy gadget - Mugglehead Magazine

Apr 22, 2025
pulisher
Apr 22, 2025

Novocure (NVCR) Gains CE Mark for Optune Lua in Lung Cancer Treatment | NVCR Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Novocure's Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer | NVCR Stock News - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer - Yahoo Finance

Apr 22, 2025
pulisher
Apr 22, 2025

LPL Financial LLC Acquires Shares of 27,861 NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 22, 2025
pulisher
Apr 19, 2025

Wedbush Issues Pessimistic Forecast for NovoCure Earnings - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

NovoCure (NVCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Apr 17, 2025
pulisher
Apr 17, 2025

Why NovoCure Stock Was Withering on Wednesday - MSN

Apr 17, 2025
pulisher
Apr 17, 2025

NovoCure (NASDAQ:NVCR) Upgraded to “Hold” at StockNews.com - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Why NovoCure (NVCR) Stock Fell Today - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Novocure price target lowered to $27 from $29 at Wedbush - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Wedbush Adjusts Price Target for Novocure (NVCR) Ahead of Earnings Report | NVCR Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 15, 2025
pulisher
Apr 12, 2025

JPMorgan Chase & Co. Has Lowered Expectations for NovoCure (NASDAQ:NVCR) Stock Price - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

11,672 Shares in NovoCure Limited (NASDAQ:NVCR) Bought by Raymond James Financial Inc. - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

NovoCure Escapes Investor Suit Over Cancer Therapy Trial Data - Bloomberg Law News

Apr 09, 2025
pulisher
Apr 09, 2025

NovoCure (NASDAQ:NVCR) Lowered to Sell Rating by StockNews.com - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

NovoCure (NASDAQ:NVCR investor three-year losses grow to 80% as the stock sheds US$133m this past week - simplywall.st

Apr 08, 2025
pulisher
Apr 03, 2025

Thrivent Financial for Lutherans Reduces Position in NovoCure Limited (NASDAQ:NVCR) - Defense World

Apr 03, 2025

Novocure Ltd Azioni (NVCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$101.51
price up icon 0.01%
medical_devices STE
$225.00
price down icon 0.60%
medical_devices PHG
$25.03
price up icon 1.25%
$68.42
price up icon 2.00%
$71.66
price up icon 1.24%
medical_devices EW
$76.04
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):